Markedly eccentric peripheral vascular stenoses: percutaneous atherectomy with an endomyocardial biopsy device
M Bulvas1, R Urbanová, R Klézlová
1Department of Medicine 2, Division of Angiology, King's Vineyards Hospital, School of Medicine 3, Charles University, Srobarova 50, Prague 10, CZ 101 00, Czech Republic. mbulv@lf1.cuni.cz
Radiology
|November 4, 2000
Summary
Percutaneous atherectomy using an endomyocardial biopsy device effectively treated lower limb artery stenoses. This novel approach significantly reduced blockages with complication rates comparable to standard angioplasty.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Medical Device Technology
Background:
- Eccentric stenoses in lower limb arteries pose significant therapeutic challenges.
- Current percutaneous transluminal angioplasty (PTA) techniques have limitations for certain lesion types.
- Novel atherectomy devices are needed to improve treatment outcomes for peripheral artery disease.
Purpose of the Study:
- To evaluate the efficacy and safety of percutaneous atherectomy using an endomyocardial biopsy device.
- To assess the treatment of eccentric stenoses in lower limb arteries.
- To compare outcomes with conventional PTA.
Main Methods:
- Percutaneous atherectomy was performed in 23 patients with 27 eccentric lower limb artery stenoses.
- An endomyocardial biopsy device was utilized for lesion treatment.
- Histopathologic examination of extracted particles was conducted.
Main Results:
- Mean percentage stenosis decreased from 82% to 14% (P < .001), indicating high efficacy.
- Histopathology confirmed the absence of media or adventitial tissue in extracted particles.
- Technical success and complication rates were comparable to conventional PTA for similar lesions.
Conclusions:
- Percutaneous atherectomy with an endomyocardial biopsy device is a safe and effective treatment for eccentric lower limb artery stenoses.
- The procedure achieves significant stenosis reduction with a favorable safety profile.
- This technique offers an alternative to conventional PTA, particularly for challenging eccentric lesions.


